Wexford Capital’s Novartis NVS Stock Holding History

Wexford Capital’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-60,399	Closed	-$4.97M	–	84
2015 Q3	$4.97M	Buy	+60,399	New	+$5.38M	0.96%	39
2015 Q1	–	Sell	-73,165	Closed	-$6.08M	–	74
2014 Q4	$6.08M	Buy	73,165 +8,604	+13%	+$713K	1.17%	14
2014 Q3	$5.45M	Buy	+64,561	New	+$5.22M	0.5%	34

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Wexford Capital's NVS Position: Q4 2015 in Review

Wexford Capital sold out of Novartis (NVS) in Q4 2015, closing a stake of 60,399 shares — an estimated $4.97M sold.

Wexford Capital first reported a position in NVS in Q3 2014 and held it in 3 quarters. The position peaked at $6.08M in Q4 2014. 926 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

Wexford Capital reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
Wexford Capital sold 60,399 Novartis shares in Q4 2015, an estimated $4.97M.
Wexford Capital first reported a position in Novartis in Q3 2014 and held it in 3 quarters.
Wexford Capital's Novartis position peaked at $6.08M in Q4 2014.
926 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Wexford Capital's 13F filing for Q4 2015, filed 11 Feb 2016.